Abstract Fatty acids (FAs) play a crucial role in human physiology, including energy production and serving as signaling molecules. However,…
Abstract The inflammatory state is a significant factor associated with diabetic kidney disease (DKD), making it one of the significant…
Abstract Background: Hypoxia is one of the most significant pathogenic factors in cardiovascular diseases. Preclinical studies suggest that nonpsychoactive cannabidiol…
Abstract Numerous strategies have been proposed to minimize obesity-associated health effects, among which phytocannabinoids appear to be effective and safe…
Abstract Background: Cannabigerol (CBG), a non-psychotropic phytocannabinoid found in Cannabis sativa plants, has been the focus of recent studies due…
Abstract Obesity is one of the principal public health concerns leading to disturbances in glucose and lipid metabolism, which is…
Abstract Cardiovascular disease (CVD) causes millions of deaths worldwide each year. Despite the great progress in therapies available for patients…
Abstract Available data suggest that cannabidiol (CBD) may ameliorate symptoms of insulin resistance by modulating the sphingolipid concentrations in particular…
Abstract It is known that metabolic disturbances, including obesity, predispose to an increased incidence of cardiovascular diseases. Elevated consumption of…
Abstract Our study aimed to examine the endothelium (vascular)-protecting effects of chronic cannabidiol (CBD) administration (10 mg/kg once daily for…